胃癌患者化疗的医护一体化干预方法与干预效果评估(4)

http://www.100md.com 2018年11月25日 《中国医学创新》 2018年第33期

     [16] Elingarami S，Liu M，Fan J，et al.Applications of nanotechnology in gastric cancer：detection and prevention by nutrition[J].Journal of Nanoscience and Nanotechnology，2014，14(1)：932-945.

    [17] Lee S J，Lee W W，Yoon H J，et al.Regional PET/CT after water gastric inflation for evaluating loco-regional disease of gastric cancer[J].European Journal of Radiology，2013，82(6)：935-942.

    [18] Monim-UI-Mehboob M，Altaf M，Fettouhi M，et al.Synthesis，spectroscopic characterization and anti-cancer properties of new gold(Ⅲ)-alkanediamine complexes against gastric，prostate and ovarian cancer cells；crystal structure of [Au2(pn)2(Cl) 2]Cl2·H2O[J].Polyhedron，2013，61：225-234.

    [19] Zhang J，Hu H，Liang S，et al.Targeted radiotherapy with tumor vascular homing trimeric GEBP11 peptide evaluated by multimodality imaging for gastric cancer[J].Journal of Controlled Release，2013，172(1)：322-329.

    [20] Hu W Q，Fang M，Zhao H L，et al.Tumor invasion unit in gastric cancer revealed by QDs-based in situ molecular imaging and multispectral analysis[J].Biomaterials，2014，35(13)：4125-4132.

    (收稿日期：2018-09-10) (本文編辑：李莹莹)(阮淑芳 袁兰 熊秋萍)

上一页 第 1 2 3 4 页

    百拇医药网 http://www.100md.com/html/paper/1674-4985/2018/33/24-3.htm